Skip to main content

Table 2 Physician-reported current acute treatment patterns in insufficient responders/sufficient responders to acute treatment for migraine

From: Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme

  Insufficient responders (N = 227) Sufficient responders (N = 311) Total (N = 538)
Number of prescribed acute regimens ever (% of total acute prescriptions)
 0 4 (1.8) 1 (0.3) 5 (0.9)
 1 147 (64.8) 211 (68.1) 358 (66.7)
 2 50 (22.0) 74 (23.9) 124 (23.1)
  ≥ 3 26 (11.5) 24 (7.7) 50 (9.3)
Prescribed acute medication type, n (%)a
 NSAIDs (including in combinations) 99 (43.6) 115 (37.0) 214 (39.8)
 Triptans 171 (75.3) 214 (68.8) 385 (71.6)
 Opioid analgesics (including in combinations) 0 0 0
Patient currently taking OTC medications, n (%) 12 (6.5) 22 (9.0) 34 (7.9)
Currently taking OTC and/or prescribed acute*
 Prescribed acute treatment only 171 (91.9) 220 (89.8) 391 (90.7)
 OTC and prescribed acute 11 (5.9) 22 (9.0) 33 (7.7)
 OTC only 1 (0.5) 0 1 (0.2)
 Taking neither 3 (1.6) 3 (1.2) 6 (1.4)
  1. Reported data are number and percentage of patients, with percentages calculated as proportion of non-missing data
  2. *p < 0.05 between insufficient responders and sufficient responders. Chi-squared or Fisher’s exact test was used
  3. aOccurring in ≥5% of patients
  4. NSAID nonsteroidal anti-inflammatory drug; OTC over the counter